Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Pestrin

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Pharmacological Research|February 28, 2016
Using CTCs for pharmacogenomic analysisChristopher D Hart, Francesca Galardi, Marta Pestrin, et al.
Breast (Edinburgh, Scotland)|November 17, 2009
Adjuvant chemotherapy--the dark side of clinical trials. Have we learnt more?Catherine Oakman, Marta Pestrin, Egidia Cantisani, et al.
Therapeutic Advances in Medical Oncology|June 15, 2018
The role of abemaciclib in treatment of advanced breast cancerAmelia McCartney, Erica Moretti, Giuseppina Sanna, et al.
The Breast Journal|July 17, 2019
Early triple negative breast cancer: Are we getting better outcomes? A retrospective analysis from a single institutionGiacomo Barchiesi, Amelia McCartney, Chiara Biagioni, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Adjuvant chemotherapy: which patient? What regimen?Natalie Turner, Laura Biganzoli, Luca Malorni, et al.
Breast (Edinburgh, Scotland)|October 1, 2013
The continued evidence from overviews: what is the clinical utility?Natalie Turner, Laura Biganzoli, Luca Malorni, et al.
Clinical Breast Cancer|December 23, 2020
A Dose-finding Study of Metronomic Oral Vinorelbine in Combination With Oral Cyclophosphamide and Bevacizumab in Patients With Advanced Breast CancerGiuseppina Sanna, Marta Pestrin, Erica Moretti, et al.
BMC Cancer|July 21, 2006
HEX expression and localization in normal mammary gland and breast carcinomaCinzia Puppin, Fabio Puglisi, Lucia Pellizzari, et al.
Molecular Oncology|December 26, 2014
Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patientsMarta Pestrin, Francesca Salvianti, Francesca Galardi, et al.
Biomolecular Detection and Quantification|April 15, 2016
Feasibility of a workflow for the molecular characterization of single cells by next generation sequencingFrancesca Salvianti, Giada Rotunno, Francesca Galardi, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Pharmacological Research|February 28, 2016
Using CTCs for pharmacogenomic analysisChristopher D Hart, Francesca Galardi, Marta Pestrin, et al.
Breast (Edinburgh, Scotland)|November 17, 2009
Adjuvant chemotherapy--the dark side of clinical trials. Have we learnt more?Catherine Oakman, Marta Pestrin, Egidia Cantisani, et al.
Therapeutic Advances in Medical Oncology|June 15, 2018
The role of abemaciclib in treatment of advanced breast cancerAmelia McCartney, Erica Moretti, Giuseppina Sanna, et al.
The Breast Journal|July 17, 2019
Early triple negative breast cancer: Are we getting better outcomes? A retrospective analysis from a single institutionGiacomo Barchiesi, Amelia McCartney, Chiara Biagioni, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Adjuvant chemotherapy: which patient? What regimen?Natalie Turner, Laura Biganzoli, Luca Malorni, et al.
Breast (Edinburgh, Scotland)|October 1, 2013
The continued evidence from overviews: what is the clinical utility?Natalie Turner, Laura Biganzoli, Luca Malorni, et al.
Clinical Breast Cancer|December 23, 2020
A Dose-finding Study of Metronomic Oral Vinorelbine in Combination With Oral Cyclophosphamide and Bevacizumab in Patients With Advanced Breast CancerGiuseppina Sanna, Marta Pestrin, Erica Moretti, et al.
BMC Cancer|July 21, 2006
HEX expression and localization in normal mammary gland and breast carcinomaCinzia Puppin, Fabio Puglisi, Lucia Pellizzari, et al.
Molecular Oncology|December 26, 2014
Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patientsMarta Pestrin, Francesca Salvianti, Francesca Galardi, et al.
Biomolecular Detection and Quantification|April 15, 2016
Feasibility of a workflow for the molecular characterization of single cells by next generation sequencingFrancesca Salvianti, Giada Rotunno, Francesca Galardi, et al.
Pageof 4